Frontlight ResearchEarly access
WithdrawnNo phase
EngageRx With Integrated Self-Measurement of Blood Pressure
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 1 Feb 2025
- Ended
- 1 Aug 2025
- Type of study
- Interventional
- Treatments tested
- EngageRx_SMBP
- Record updated
- 7 April 2025
- Why it stopped
- Study deemed not human subjects research and will proceed as quality improvement.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adult patient (18+ years old) with uncontrolled BP in an office visit
- Lowest SBP>140 or lowest DBP>90 during the visit at one of the Mt. Zion General Internal Medicine practices
- Speaks English or Spanish
Who cannot take part
- If patient is unlikely to be able to use a home BP monitor
- Cannot understand the verbal consent
Where in United States
- University of California San FranciscoSan Francisco, United States
About the trial
What the trial wants to find out
This pilot study will support use of EngageRx_SMBP for 70 patients in the UCSF General Internal Medicine practice. The goals of the pilot will be to assess usability and satisfaction of both patients and clinicians, and to describe BP-related process metrics and outcomes including time to intensification of BP medications and/or BP control.
The group in the trial
- EngageRx_SMBPTreatment being tested
Integrated SMBP monitoring using EngageRx\_SMBP.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 April 2025